Cormorant Asset Management LP 13D and 13G filings for Turning Point Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:02 pm Purchase | 2021-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX | Cormorant Asset Management LP | 3,025,000 6.110% | 632,703 (+26.45%) | Filing |
| 2021-02-16 3:12 pm Sale | 2020-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX | Cormorant Asset Management LP | 2,392,297 4.960% | -1,004,353 (-29.57%) | Filing |